Selected research
Industry Research
Cell Culture & Live-Cell Imaging Systems Industry Research Report 2026
Market perspective
The global Cell Culture & Live-Cell Imaging Systems market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cell Culture & Live-Cell Imaging Systems market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cell Culture & Live-Cell Imaging Systems market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cell Culture & Live-Cell Imaging Systems market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cell Culture & Live-Cell Imaging Systems include Thermo Fisher Scientific, Nikon, Agilent Technologies, Sartorius, Yokogawa Electric, Molecular Devices, Bruker, Oxford Instruments Andor and Keyence, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cell Culture & Live-Cell Imaging Systems market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell Culture & Live-Cell Imaging Systems.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell Culture & Live-Cell Imaging Systems Market by Company
Thermo Fisher Scientific
Nikon
Agilent Technologies
Sartorius
Yokogawa Electric
Molecular Devices
Bruker
Oxford Instruments Andor
Keyence
CytoSMART Technologies
Novel Optics
Sunny Optical Technology
Phoenix Optical
Carl Zeiss
Danaher
Evident
Cell Culture & Live-Cell Imaging Systems Segment by Type
Live-Cell Imaging Systems
Automated Cell Culture Systems
High-Content Screening (HCS) Systems
Confocal Live-Cell Imaging Systems
Fluorescence Imaging Systems
Label-Free Imaging Systems
Integrated Cell Culture & Imaging Platforms
Cell Culture & Live-Cell Imaging Systems Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
Clinical Research Laboratories
Government and Public Health Laboratories
Cell Culture & Live-Cell Imaging Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Culture & Live-Cell Imaging Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Culture & Live-Cell Imaging Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Culture & Live-Cell Imaging Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell Culture & Live-Cell Imaging Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Live-Cell Imaging Systems
- Automated Cell Culture Systems
- High-Content Screening (HCS) Systems
- Confocal Live-Cell Imaging Systems
- Fluorescence Imaging Systems
- Label-Free Imaging Systems
- Integrated Cell Culture & Imaging Platforms
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Clinical Research Laboratories
- Government and Public Health Laboratories
Companies covered
- Thermo Fisher Scientific
- Nikon
- Agilent Technologies
- Sartorius
- Yokogawa Electric
- Molecular Devices
- Bruker
- Oxford Instruments Andor
- Keyence
- CytoSMART Technologies
- Novel Optics
- Sunny Optical Technology
- Phoenix Optical
- Carl Zeiss
- Danaher
- Evident
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell Culture & Live-Cell Imaging Systems by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Live-Cell Imaging Systems
- 2.2.3 Automated Cell Culture Systems
- 2.2.4 High-Content Screening (HCS) Systems
- 2.2.5 Confocal Live-Cell Imaging Systems
- 2.2.6 Fluorescence Imaging Systems
- 2.2.7 Label-Free Imaging Systems
- 2.2.8 Integrated Cell Culture & Imaging Platforms
- 2.3 Cell Culture & Live-Cell Imaging Systems by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Biotechnology Companies
- 2.3.4 Academic and Research Institutes
- 2.3.5 Contract Research Organizations (CROs)
- 2.3.6 Clinical Research Laboratories
- 2.3.7 Government and Public Health Laboratories
- 2.4 Assumptions and Limitations
3 Cell Culture & Live-Cell Imaging Systems Breakdown Data by Type
- 3.1 Global Cell Culture & Live-Cell Imaging Systems Historic Market Size by Type (2021-2026)
- 3.2 Global Cell Culture & Live-Cell Imaging Systems Forecasted Market Size by Type (2027-2032)
4 Cell Culture & Live-Cell Imaging Systems Breakdown Data by Application
- 4.1 Global Cell Culture & Live-Cell Imaging Systems Historic Market Size by Application (2021-2026)
- 4.2 Global Cell Culture & Live-Cell Imaging Systems Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell Culture & Live-Cell Imaging Systems Market Perspective (2021-2032)
- 5.2 Global Cell Culture & Live-Cell Imaging Systems Growth Trends by Region
- 5.2.1 Global Cell Culture & Live-Cell Imaging Systems Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell Culture & Live-Cell Imaging Systems Historic Market Size by Region (2021-2026)
- 5.2.3 Cell Culture & Live-Cell Imaging Systems Forecasted Market Size by Region (2027-2032)
- 5.3 Cell Culture & Live-Cell Imaging Systems Market Dynamics
- 5.3.1 Cell Culture & Live-Cell Imaging Systems Industry Trends
- 5.3.2 Cell Culture & Live-Cell Imaging Systems Market Drivers
- 5.3.3 Cell Culture & Live-Cell Imaging Systems Market Challenges
- 5.3.4 Cell Culture & Live-Cell Imaging Systems Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell Culture & Live-Cell Imaging Systems Players by Revenue
- 6.1.1 Global Top Cell Culture & Live-Cell Imaging Systems Players by Revenue (2021-2026)
- 6.1.2 Global Cell Culture & Live-Cell Imaging Systems Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell Culture & Live-Cell Imaging Systems Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell Culture & Live-Cell Imaging Systems Head Office and Area Served
- 6.4 Global Cell Culture & Live-Cell Imaging Systems Players, Product Type & Application
- 6.5 Global Cell Culture & Live-Cell Imaging Systems Manufacturers Established Date
- 6.6 Global Cell Culture & Live-Cell Imaging Systems Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell Culture & Live-Cell Imaging Systems Market Size (2021-2032)
- 7.2 North America Cell Culture & Live-Cell Imaging Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell Culture & Live-Cell Imaging Systems Market Size by Country (2021-2026)
- 7.4 North America Cell Culture & Live-Cell Imaging Systems Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell Culture & Live-Cell Imaging Systems Market Size (2021-2032)
- 8.2 Europe Cell Culture & Live-Cell Imaging Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell Culture & Live-Cell Imaging Systems Market Size by Country (2021-2026)
- 8.4 Europe Cell Culture & Live-Cell Imaging Systems Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Culture & Live-Cell Imaging Systems Market Size (2021-2032)
- 9.2 Asia-Pacific Cell Culture & Live-Cell Imaging Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell Culture & Live-Cell Imaging Systems Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell Culture & Live-Cell Imaging Systems Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell Culture & Live-Cell Imaging Systems Market Size (2021-2032)
- 10.2 South America Cell Culture & Live-Cell Imaging Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell Culture & Live-Cell Imaging Systems Market Size by Country (2021-2026)
- 10.4 South America Cell Culture & Live-Cell Imaging Systems Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Culture & Live-Cell Imaging Systems Market Size (2021-2032)
- 11.2 Middle East & Africa Cell Culture & Live-Cell Imaging Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell Culture & Live-Cell Imaging Systems Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell Culture & Live-Cell Imaging Systems Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Nikon
- 12.2.1 Nikon Company Information
- 12.2.2 Nikon Business Overview
- 12.2.3 Nikon Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.2.4 Nikon Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.2.5 Nikon Recent Developments
- 12.3 Agilent Technologies
- 12.3.1 Agilent Technologies Company Information
- 12.3.2 Agilent Technologies Business Overview
- 12.3.3 Agilent Technologies Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.3.4 Agilent Technologies Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.3.5 Agilent Technologies Recent Developments
- 12.4 Sartorius
- 12.4.1 Sartorius Company Information
- 12.4.2 Sartorius Business Overview
- 12.4.3 Sartorius Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.4.4 Sartorius Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.4.5 Sartorius Recent Developments
- 12.5 Yokogawa Electric
- 12.5.1 Yokogawa Electric Company Information
- 12.5.2 Yokogawa Electric Business Overview
- 12.5.3 Yokogawa Electric Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.5.4 Yokogawa Electric Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.5.5 Yokogawa Electric Recent Developments
- 12.6 Molecular Devices
- 12.6.1 Molecular Devices Company Information
- 12.6.2 Molecular Devices Business Overview
- 12.6.3 Molecular Devices Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.6.4 Molecular Devices Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.6.5 Molecular Devices Recent Developments
- 12.7 Bruker
- 12.7.1 Bruker Company Information
- 12.7.2 Bruker Business Overview
- 12.7.3 Bruker Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.7.4 Bruker Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.7.5 Bruker Recent Developments
- 12.8 Oxford Instruments Andor
- 12.8.1 Oxford Instruments Andor Company Information
- 12.8.2 Oxford Instruments Andor Business Overview
- 12.8.3 Oxford Instruments Andor Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.8.4 Oxford Instruments Andor Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.8.5 Oxford Instruments Andor Recent Developments
- 12.9 Keyence
- 12.9.1 Keyence Company Information
- 12.9.2 Keyence Business Overview
- 12.9.3 Keyence Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.9.4 Keyence Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.9.5 Keyence Recent Developments
- 12.10 CytoSMART Technologies
- 12.10.1 CytoSMART Technologies Company Information
- 12.10.2 CytoSMART Technologies Business Overview
- 12.10.3 CytoSMART Technologies Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.10.4 CytoSMART Technologies Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.10.5 CytoSMART Technologies Recent Developments
- 12.11 Novel Optics
- 12.11.1 Novel Optics Company Information
- 12.11.2 Novel Optics Business Overview
- 12.11.3 Novel Optics Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.11.4 Novel Optics Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.11.5 Novel Optics Recent Developments
- 12.12 Sunny Optical Technology
- 12.12.1 Sunny Optical Technology Company Information
- 12.12.2 Sunny Optical Technology Business Overview
- 12.12.3 Sunny Optical Technology Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.12.4 Sunny Optical Technology Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.12.5 Sunny Optical Technology Recent Developments
- 12.13 Phoenix Optical
- 12.13.1 Phoenix Optical Company Information
- 12.13.2 Phoenix Optical Business Overview
- 12.13.3 Phoenix Optical Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.13.4 Phoenix Optical Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.13.5 Phoenix Optical Recent Developments
- 12.14 Carl Zeiss
- 12.14.1 Carl Zeiss Company Information
- 12.14.2 Carl Zeiss Business Overview
- 12.14.3 Carl Zeiss Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.14.4 Carl Zeiss Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.14.5 Carl Zeiss Recent Developments
- 12.15 Danaher
- 12.15.1 Danaher Company Information
- 12.15.2 Danaher Business Overview
- 12.15.3 Danaher Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.15.4 Danaher Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.15.5 Danaher Recent Developments
- 12.16 Evident
- 12.16.1 Evident Company Information
- 12.16.2 Evident Business Overview
- 12.16.3 Evident Revenue in Cell Culture & Live-Cell Imaging Systems Business (2021-2026)
- 12.16.4 Evident Cell Culture & Live-Cell Imaging Systems Product Portfolio
- 12.16.5 Evident Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst